Save the date, and share your story at a drug development meeting on autoimmune hepatitis on Friday, January 27, 2023.
Externally-Led Patient Focused Drug Development Meeting (EL-PFDD) on Autoimmune Hepatitis
Friday, January 27, 2023
10 a.m.-2:30 p.m. ET
Thanks for Attending
Thanks to everyone who attended the Externally-Led Patient Focused Drug Development Meeting (EL-PFDD) on Autoimmune Hepatitis, which was held virtually on January 27, 2023.
View the Recording
The recording from the meeting is now available to view.
Access the meeting agenda.
The Overall Goal
The goal of the meeting, which was open to all, was to provide the U.S. Food and Drug Administration (FDA), drug developers, doctors, and academic researchers opportunities to hear from AIH patients about the impact the disease has on their health and daily life. It was also a chance for patients to share their views of currently available therapies and goals for treatment.
The AIHA hopes this important meeting highlighted the need for new treatments that work for all patients and that have fewer side effects.